
Tesla's $243 Million Autopilot Verdict Reveals a Glaring Flaw
An unusual aspect of this case, Benavides v. Tesla, was that the driver admitted he was at fault, having sped through a stop sign while searching for a dropped cellphone, killing Naibel Benavides Leon and seriously injuring her boyfriend as they stood next to their parked SUV. The jury did indeed blame the distracted driver but assigned him only two-thirds of that blame. The rest was laid on Tesla. Not only must it pay its share of compensatory damages to the victims, amounting to about $43 million, but also $200 million of punitive damages.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNN
a few seconds ago
- CNN
Linda Yaccarino, who just left Elon Musk's X, has a new job
Linda Yaccarino, the former CEO of the Elon Musk-owned social media platform X, has a new leadership gig in the weight loss space. Yaccarino on Tuesday was named the CEO of eMed, a Miami-based telehealth company that dispenses GLP-1 medications such as Wegovy and Ozempic. The appointment marks a shift for Yaccarino, who has a background largely in marketing, advertising and media world. Prior to joining X, Yaccarino worked in various advertising and global partnerships for NBCUniversal and Turner for several decades. In a press release, eMed said that Yaccarino is arriving in a 'game-changing moment' in the company's five-year old history, which is to 'make safe, effective and sustainable chronic care accessible directly through an all-in-one, digital-first experience.' The company added that her experience would be 'instrumental' as it looks to accommodate more 'national and global employer and government partnerships.' 'The healthcare industry has been disrupted by technology, but not yet completely transformed by it,' Yaccarino said in a press release. 'There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that impact consumers directly in ways that have never been done before.' EMed got its start during the height of the pandemic in 2020, offering Covid tests and services. However, it has since pivoted to weight loss drugs, joining Weight Watchers, which recently exited bankruptcy and is forging a similar path of selling GLP-1 drugs online. Yaccarino didn't immediately respond to CNN's request for comment. She joined X, then called Twitter, in June 2023, which was about eight months after Musk bought the social media platform. Her main task was to help fix the platform's flagging advertising business, after the billionaire alienated brands with his controversial comments and changes to the platform. But her tenure had been marked by repeated public relations crises, including scrutiny over antisemitic and other hateful content spreading on the platform, viral false claims around international conflicts and ads that appeared alongside pro-Nazi content on the site. That led some brands to pull their spending, for which the Yaccarino-led X sued an advertising industry group — a lawsuit Yaccarino announced in a video message to all X users, in which she decried what she referred to as a conspiracy to boycott the X platform. (The industry group, Global Alliance for Responsible Media, shut down days after the lawsuit was filed.) A day before she announced her departure, the company's Grok chatbot began pushing antisemitic tropes in responses to users, however it wasn't clear that her exit was connected to that incident. The company later apologized. CNN's Clare Duffy contributed to this report.


CNN
a minute ago
- CNN
Linda Yaccarino, who just left Elon Musk's X, has a new job
Linda Yaccarino, the former CEO of the Elon Musk-owned social media platform X, has a new leadership gig in the weight loss space. Yaccarino on Tuesday was named the CEO of eMed, a Miami-based telehealth company that dispenses GLP-1 medications such as Wegovy and Ozempic. The appointment marks a shift for Yaccarino, who has a background largely in marketing, advertising and media world. Prior to joining X, Yaccarino worked in various advertising and global partnerships for NBCUniversal and Turner for several decades. In a press release, eMed said that Yaccarino is arriving in a 'game-changing moment' in the company's five-year old history, which is to 'make safe, effective and sustainable chronic care accessible directly through an all-in-one, digital-first experience.' The company added that her experience would be 'instrumental' as it looks to accommodate more 'national and global employer and government partnerships.' 'The healthcare industry has been disrupted by technology, but not yet completely transformed by it,' Yaccarino said in a press release. 'There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that impact consumers directly in ways that have never been done before.' EMed got its start during the height of the pandemic in 2020, offering Covid tests and services. However, it has since pivoted to weight loss drugs, joining Weight Watchers, which recently exited bankruptcy and is forging a similar path of selling GLP-1 drugs online. Yaccarino didn't immediately respond to CNN's request for comment. She joined X, then called Twitter, in June 2023, which was about eight months after Musk bought the social media platform. Her main task was to help fix the platform's flagging advertising business, after the billionaire alienated brands with his controversial comments and changes to the platform. But her tenure had been marked by repeated public relations crises, including scrutiny over antisemitic and other hateful content spreading on the platform, viral false claims around international conflicts and ads that appeared alongside pro-Nazi content on the site. That led some brands to pull their spending, for which the Yaccarino-led X sued an advertising industry group — a lawsuit Yaccarino announced in a video message to all X users, in which she decried what she referred to as a conspiracy to boycott the X platform. (The industry group, Global Alliance for Responsible Media, shut down days after the lawsuit was filed.) A day before she announced her departure, the company's Grok chatbot began pushing antisemitic tropes in responses to users, however it wasn't clear that her exit was connected to that incident. The company later apologized. CNN's Clare Duffy contributed to this report.
Yahoo
29 minutes ago
- Yahoo
Jim Cramer Highlights Microsoft's $4 Trillion Moment and AI-Driven Strength
Microsoft Corporation (NASDAQ:MSFT) is one of the stocks that Jim Cramer spoke about. During the episode, Cramer discussed the company's recently posted strong earnings. He said: 'What should it have been about? Well, how about Microsoft? How about Meta? Nope. They were overshadowed by the Fig-Man Carnival. It was all anyone talked about down here. Call me old-fashioned, but I really wanted the market today to be defined by those earnings reports from two tech titans. I'm talking about Microsoft, briefly a $4 trillion company today, before closing just below that level, and Meta at just under $2 trillion. I wanted these to be foundational… Pixabay/Public Domain Microsoft Corporation (NASDAQ:MSFT) provides software, cloud services, devices, and AI-driven tools across productivity, business applications, and personal computing. The company's major platforms include Microsoft 365, Azure, LinkedIn, Xbox, , and WGitHubindows. While we acknowledge the potential of MSFT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data